Zusammenfassung
Die Sklerosierungstherapie hat ihren festen Stellenwert in der Behandlung von retikulären Varizen und Seitenästen. Durch die Einführung der Sklerosierung mit aufgeschäumten Verödungsmitteln konnte die Effektivität bei großen Varizen und der Stammvarikose deutlich gesteigert werden. Bei niedriger Nebenwirkungsrate und guter Kosten-Nutzen-Relation stellt die Sklerosierung subkutaner Varizen mit aufgeschäumten Verödungsmitteln eine Alternative und eine Ergänzung zu den operativen und endovenösen Verfahren dar.
Der Stellenwert der Schaumsklerosierung im Vergleich zu den anderen Therapieverfahren muss in randomisierten Vergleichsstudien überprüft werden.
Abstract
Sclerotherapy is a standardized method in the treatment of reticular veins and tributary varicose veins. The use of foamed sclerosing agents has improved the effectivity of the method also for large subcutaneous veins and saphenous veins. With a low profile of side effects and good cost effectiveness, foam sclerotherapy is an alternative and additional method to operative and endovenous treatment of varicose veins. The position of this method in comparison with the other options has to be defined by randomized comparative studies in the future.
Literatur
Baccaglini U, Spreafico G, Castoro C, Sorrentino P (1997) Consensus conference on sclerotherapy or varicose veins of the lower limbs. Phlebology 12: 2–16
Baccaglini U, Stemmer R, Partsch U (1997) Internationale Fragebogenaktion zur Praxis der Verödungsbehandlung. Phlebologie 26: 129–142
Barrett JM, Allen B, Ockelford A, Goldmann M (2004) Microfoam ultrasound—guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 30: 6–12
Benigni JP, Sadoun S, Thirion V et al. (1999 ) Télangictasies et varices réticulaires. Traitement par la mousse d’aetoxisclérol –290
Bergan JJ, Weiss RA, Goldman MP (2000) Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 26: 535–542
Breu FX, Guggenbichler S (2004) European Consensus Meeting on Foam Sclerotherapy, April 4–6 2003, Tegernsee, Germany. Dermatol Surg 30: 709–717
Cavezzi A, Frullini A (1998) Echosclerotherapy in the short saphenous vein insufficiency: personal experience. Abstract UIP, Sydney
Cavezzi A, Frullini A (1998) Il ruola della mousse sclerosante nella ecosclerosi safenica e delle varici recidive. Esperienza personale. Flebologia 9: 1–3
Conrad P, Malouf GM, Stacey MC (1994) The Australian polidocanol (aethoxysklerol) study. Results at 1 year. Phlebology 9: 17–20
Conrad P, Malouf GM, Stacey MC (1995) The Australian polidocanol (aethoxysklerol) study. Results at 2 years. Dermatol Surg 21/4: 334–336
Drake LA, Dinehart SM, Goltz RW et al. (1996) Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins. J Am Acad Dermatol 34: 523–528
Dover J, Sadick N, Goldman MP (1999) The role of lasers and light sources in the treatment of leg veins. Derm Surg 25: 328–336
Einarsson E, Eklöf B, Neglén P (1993) Sclerotherapy or surgery as treatment for varicose veins: A prospective randomized study. Phlebology 8: 22–26
Fegan WG (1963) Continous compression technique of infecting varicose veins. Lancet 1:109–112
Feied CF (1993) Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states. Semin Dermatol 12/2: 135–149
Feied CF, Jackson JJ, Bren TS et al. (1994) Allergic reactions to polidocanol for vein sclerosis. J Dermatol Surg Oncol: 20: 466–468
Feuerstein W (1973) Schwere anaphylaktische Reaktion auf Hydroxypolyaethoxydodecan. Vasa 3/2: 292–294
Fisher DA (2000) Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 26/11: 1081
Flückiger P (1956) Nichtoperative retrograde Varizenverödung mit Varisylschaum. Schweiz Med Wochenschr 48: 1368–1370
Frullini A, Cavezzi A (1999) Ultrasound guided sclerotherapy in the treatment of long saphenaous vein insufficiency. Vasomed 11 [Suppl 1]: 8
Frullini A (2002 ) Sclerosing foam in the treatment of recurrent varicose veins In: Henriet J P (ed) Foam sclerotherapy state of the art. Editions Phlébologiques Françaises, pp 73–78
Frullini A, Cavezzi A (2002) Sclerosing foam in the treatment of varicose veins and teleangiectases: history and analyses of safety and complications. Dermatol Surg 28: 11–15
Frullini A (2000) New technique in producing sclerosing faom in a disposable syringe. Dermatol Surg 26: 705–796
Georgiev M (1993) Postsclerotherapy hyperpigmentations. J Dermatol Surg Oncol 19: 649–652
Geukens J, Rabe E, Bieber T (1999) Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol 9: 132–133
Gobin JP (2001) The sclerotherapy position in recurrent varicose veins treatment, 14. UIP’01, 09–14.09.2001, Rom. Int Angiology 20/2 [Suppl 1]: 336
Goldman PM (1989) Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias. J Dermatol Surg Oncol 15: 204–209
Goldman PM, Beaudoing D, Marley W, Lopez L, Butie A (1990) Compression in the treatment of leg teleangiectasia: a preliminary report. J Dermatol Surg Oncol 16: 322–325
Goldman MP, Sadick NS, Weiss RA (1995) Cutaneous necrosis, telangiectatic matting and hyperpigmentation following sclerotherapy. Dermatol Surg 21: 19–29
Goldmann PM (1996) Complications of sclerotherapy. In: Gloviczki, P, J Yao (eds) Handbook of venous disorders. Chapmann & Hall Medical, London, pp 374–393
Grondin L, Young R, Wouters L (1997) Sclérothérapie ècho-guidée et sécurité: Comparison des techniques. Phlebologie 50/2: 241–245
Guex JJ (2000) Ultrasound guided sclerotherapy (USGS) for perforating veins. Hawaii Med J 59/6: 261–262
Härtel SL (1998) Fünf-Jahres-Nachuntersuchungsergebnisse der Sklerosierungstherapie nach Stemmer bei 118 Patienten mit primärer Varikosis. Vasomed 4: 272–273
Hamel-Desnos C, Desnos P, Ouvry P (2003 ) Nouveautés thérapeutiques dans la prise en charge de la maladie variqueuse: écho-sclérothérapie et mousse. Phlébologie 56/1: 41
Hamel-Desnos C, Desnos P, Wollmann JC et al. (2003) Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: Initial Results. Dermatol Surg 29: 1170–1175
Henriet JP (1997) One year experience with sclerotherapy of reticular veins and telangiectases using polidocanol foam in daily routine: feasibility results, complications. Phlébologie 50/3: 355–360
Hohlbaum G (1990) Über iatrogene Schäden bei der Varizensklerosierung. In: Staubesand J, Schöpf E (Hrsg) Neuere Aspekte der Sklerosierungstherapie. Springer, Berlin Heidelberg New York Tokio, S 70–81
Hübner K (1991) Ambulante Therapie der Stammvarikose mittels Krossektomie und Sklerotherapie—ein Beitrag aus der Praxis des niedergelassenen Phlebologen. Phlebologie 20: 104–108
Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D (2004) Single-blind, randomized study comparing chromated glycerin, Polidocanol Solution and Polidocanol Foam for Treatment Teleangiectatic leg veins. Dermatol Surg 30: 367–372
Kersting E, Hornschuh B, Bröcker E-B (1998) Embolia cutis medicamentosa nach Varizensklerosierung mit Polidocanol. Phlebologie 27: 55–57
Kreussler (1996) Aethoxysklerol-Fachinformation der Herstellerfirma, Chemische Fabrik Kreussler & Co GmbH, Stand: 2/1996
Malouf GM (2000) Ambulatory venous surgery versus sclerotherapy. Hawaii Med J 59: 248–249
Massay RA (1999) Regarding the use of compression stockings after sclerotherapy. Dermatol Surg 25: 517
Mayer H, Brücke H (1957) Zur Ätiologie und Behandlung der Varizen der unteren Extremität. Chir Praxis 4: 521–528
McCoy S, Evans A, Spurrier N (1999) Sclerotherapy for leg telangiectasia—a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 25: 381–386
Mc Donagh B (1999) Comments on the use of post-sclerotherapy compression. Dermatol Surg 25/6: 519–521
Monfreux A (1997) Traitement sclérosant des troncs saphèniens et leurs collatèrales de gros calibre par la méthode mus. Phlébologie 50/3: 351–353
Norris MJ, Carlin MC, Ratz JL (1989) Treatment of essential telangiectasia: Effects of increasing concentrations of polidocanol. J Am Acad of Dermatol 20/4: 643–649
Oesch A, Stirnemann P, Mahler F (1984) The acute ischemic syndrome of the foot after sclerotherapy of varicose veins. Schweiz Med Wochenschr 114: 1155–1158
Pradalier A, Vincent D, Hentschel V, Cohen-Jonathan AM, Daniel E (1995) Allergie aux sclérosants des varices. Rev Fr Allergol 35/5: 440–443
Rabe E (Hrsg) (2003) Grundlagen der Phlebologie, 3. Aufl. Viavital, Köln
Rabe E, Pannier-Fischer F, Gerlach H et al. (2003) Leitlinien zur Sklerosierungsbehandlung der Varikose. Phlebologie 32: 101–107
Rabe E, Pannier-Fischer F, Gerlach H et al. (2004) Guidelines for sclerotherapy of varicose veins. Dermatol Surg 30: 687–693
Reddy P, Wickers J, Terry T et al. (1986) What is the correct period of bandaging following sclerotherapy? Phlebology 39: 217–220
Remy W, Vogt H-J, Borelli S (1978) Embolia cutis medicamentosa—artige Hautnekrosen nach Sklerosierungsbehandlung. Phlebol Proktol 7: 67–72
Sadoun S, Benigni JP (1999) La mousse de sclérosant: état de l’art. In: Rabe E et al. (ed) Phlebology ‚99. Viavital, Köln, S 146
Seydewitz V, Staubesand J (1990) Das ultrastrukturelle Substrat der Wirkung paravasal und intraarteriell applizierter Sklerosierungsmittel: Ein experimenteller Beitrag zum Problem iatrogener Schäden nach Sklerotherapie. In: Staubesand J, Schöpf E (Hrsg) Neuere Aspekte der Sklerosierungstherapie. Springer, Berlin Heidelberg New York Tokio, S 40–65
Sigg K (1949) Neuere Gesichtspunkte zur Technik der Varizenbehandlung. Ther Umschau 6: 127–134
Schadeck M (1996) Duplex-kontrollierte Sklerosierungsbehandlung der Vena saphena magna. Phlebologie 25: 78–82
Schadeck M, Allaert FA (1997) Résultats à long terme de la sclérothérapie des saphènes internes. Phlebologie 50/2: 257–262
Schadeck M (1999) Echo-sclerotherapy. Phlébologie 52 (Special Issue 10): 103–106
Schultz-Ehrenburg U, Tourbier H (1984) Doppler-kontrollierte Verödungsbehandlung der V. saphena magna. Phlebol Proktol 13: 117–122
Stanley PR, Bickerton DR, Campbell WB (1991) Injection sclerotherapy for varicose veins—a comparison of materials for applying local compression. Phlebology 44: 37–39
Tazelaar DJ, Neumann HA, Roos KP de (1999) Long cotton wool rolls as compression enhancers in macrosclerotherapy for varicose veins. Dermatol Surg 25/1: 38–40
Tessari L, Cavezzi A, Frullini A (2001) Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 27: 58–60
Tessari L (2000) Nouvelle technique d’obtention de la sclèro-mousse. Phlébologie 53/1: 129
Van Neer PAFA (2004) Perforans varicosis: treatment of incompetent perforating vein is important. Dermatol Surg 30: 754–755
Van der Plas JP, Lambers JC, van Wersch JW, Koehler PJ (1994) Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 343 (8894): 428
Villavicencio J, Pfeifer J, Lohr J et al. (1996) Sclerotherapy for varicose veins: Practice guidelines and sclerotherapy procedures. In: Glovicki P, Yao J (eds) Handbook of venous disorders. Chapmann & Hall Medical, London, pp 337–354
Vin F (1997) Principes de la sclérothérapie des troncs saphènes internes. Phlebologie 50/2: 229–234
Weiss RA, Weiss MA (1990) Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonics saline vs. polidocanol. J Dermatol Surg Oncol 16: 800–804
Weiss RA, NS Sadick, MP Goldman, MA Weiss (1999) Post-sclerotherapy compression: Controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 25: 105–108
Wenner L (1986) Improvement of immediate and long-term results in sclerotherapy. Vasa 15: 180–183
Wollmann JC (2002 ) Schaum—zwischen Vergangenheit und Zukunft. 8. Bonner Venentage 15.–16. Feb. Vasomed 16/1: 34 –38
Wollmann JC (2004) The history of sclerosing foams. Dermatol Surg 30: 694–703
Yamaki T, Nozaki M, Sasaki K (2000) Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 26/4: 323–328
Yamaki T, Nozaki M, Fujiwara O, Yoshida E (2002) Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face. Dermatol Surg 28/7: 619–622
Yamaki T, Nozaki M, Iwasaka S (2004) Comparative study of duplex-guided foam sclerotherapy and duplex guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 30: 718–722
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pannier, F., Rabe, E. Schaumsklerosierung der Varikose. Gefässchirurgie 9, 284–289 (2004). https://doi.org/10.1007/s00772-004-0368-x
Issue Date:
DOI: https://doi.org/10.1007/s00772-004-0368-x